혈관질환 억제 효능이 있는 BDR-29의 백서 신장 독성연구

Study on Kidney Toxicity of BDR-29 for Treatment Vascular Diseases in Rats

  • 김은주 (원광대학교 한의학전문대학원 한약자원개발학) ;
  • 강대길 (원광대학교 한의학전문대학원 한약자원개발학) ;
  • 이안숙 (원광대학교 한의학전문대학원 한약자원개발학) ;
  • 최덕호 (원광대학교 한의학전문대학원 한약자원개발학) ;
  • 조국현 (원광대학교 한의학전문대학원 한약자원개발학) ;
  • 김성연 (원광대학교 약학대학교 약학과) ;
  • 이호섭 (원광대학교 한의학전문대학원 한약자원개발학)
  • Kim, Eun-Ju (Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Kang, Dae-Gill (Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Lee, An-Sook (Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Choi, Deok-Ho (Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Cho, Kuk-Hyun (Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Kim, Sung-Yun (Dept. of Pharmacy, College of Pharmacy, Wonkwang University) ;
  • Lee, Ho-Sub (Professional Graduate School of Oriental Medicine, Wonkwang University)
  • 발행 : 2008.12.30

초록

The kidney toxicities of BDR-29 used for improvement of the vascular diseases, was examined using male and female Sprague-Dawley rats. The male and female rats were divided into 4 groups for intragastrical treatment with doses of 0, 5, 50, and 500 mg/kg/day for 13 weeks, respectively. In all male and female rats treated with BDR-29, no mortality and gross pathological findings were shown for 13 weeks. There substantially was no change in body weight in all rats with treatment of BDR-29. The renal functional parameters including urinary volume, urine osmolality, electrolytes excretory rate, creatinine clearance, and solute-free water reabsorption were not exchanged in all rats treated with BDR-29. Taken together, these results suggest that BDR-29 has no toxicity on kidney in all male and female rats.

키워드